Emergent BioSolutions Inc. (EBS) NYSE
7.96
-0.49(-5.80%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.96
-0.49(-5.80%)
Currency In USD
| Previous Close | 8.45 |
| Open | 8.4 |
| Day High | 8.4 |
| Day Low | 7.93 |
| 52-Week High | 14.06 |
| 52-Week Low | 4.34 |
| Volume | 485,829 |
| Average Volume | 939,911 |
| Market Cap | 412.1M |
| PE | 8.56 |
| EPS | 0.93 |
| Moving Average 50 Days | 9.38 |
| Moving Average 200 Days | 9.5 |
| Change | -0.49 |
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
GlobeNewswire Inc.
Mar 03, 2026 1:00 PM GMT
GAITHERSBURG, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of John D. Fowler, Jr. to its board of directors effective March 1, 2026. Mr. Fowler brings more than three decades of lead
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
GlobeNewswire Inc.
Feb 26, 2026 9:01 PM GMT
GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors authorized the repurchase of up to $50 million of the company’s common stock on or before March 31, 2027. This a
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada’s Leadership in Health Preparedness
GlobeNewswire Inc.
Feb 26, 2026 9:01 PM GMT
WINNIPEG, Manitoba, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced a series of new contracts and a contract modification with the Public Health Agency of Canada (PHAC) and the Department of National Defence (DND